Plessi-ER 0.375 Tablet
By Plessi
Rx
10 Tablet ER in a Strip

Composition
Pramipexole(0.375mg)

Manufacturer - Consern Pharma Limited
Consern Pharma Private Limited, Kuljive Mahajan(Mg. Director), Rural Focal Point, V.P.O. Tibba, Ludhiana - 141120, Punjab, India

Expires on or after
September, 2025

liver
Plessi-ER 0.375 Tablet is considered safe for individuals with liver disease based on the limited available data. It appears that adjusting the dosage of Plessi-ER 0.375 Tablet may not be necessary for these patients. However, it is always recommended to consult with your healthcare provider for personalized advice and guidance regarding the use of this medication in relation to liver issues.

kidney
Plessi-ER 0.375 Tablet needs caution in kidney disease. Dose adjustment may be necessary. Consult your doctor.

alcohol
When alcohol is consumed with Plessi-ER 0.375 Tablet, it can lead to increased drowsiness.

driving
Caution is advised when driving while taking Plessi-ER 0.375 Tablet as it may cause hallucinations that can impact your driving ability.

pregnancy
Plessi-ER 0.375 Tablet may not be safe to use during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will consider the benefits and risks before prescribing this medication to you. Consult your doctor for advice.

breastfeeding
Caution should be taken when breastfeeding while using Plessi-ER 0.375 Tablet as it may be unsafe. Limited data indicates the drug can pass into breastmilk and potentially harm the baby. It also suppresses serum prolactin, which could affect breastfeeding.
Habit Forming | No |
Chemical Class | Benzothiazole Derivative |
Therapeutic Class | NEURO CNS |
Action Class | Dopamine agonists |
₹95
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024